Cross-Talk and Subset Control of Microglia and Associated Myeloid Cells in Neurological Disorders
Neurological disorders are highly prevalent and often lead to chronic debilitating disease. Neuroinflammation is a major driver across the spectrum of disorders, and microglia are key mediators of this response, gaining wide acceptance as a druggable cell target. Moreover, clinical providers have li...
Main Authors: | Jatia Mills, Liliana Ladner, Eman Soliman, John Leonard, Paul D. Morton, Michelle H. Theus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/21/3364 |
Similar Items
-
Myeloid-specific blockade of notch signaling alleviates dopaminergic neurodegeneration in Parkinson’s disease by dominantly regulating resident microglia activation through NF-κB signaling
by: Shi-Qian Liang, et al.
Published: (2023-08-01) -
Editorial: Dysfunctional microglia in neurological disorders
by: Anup Bhusal, et al.
Published: (2023-01-01) -
Myeloperoxidase as a Marker to Differentiate Mouse Monocyte/Macrophage Subsets
by: Cody J. Gurski, et al.
Published: (2022-07-01) -
The role of microglia and myeloid immune cells in acute cerebral ischemia
by: Corinne eBenakis, et al.
Published: (2015-01-01) -
Clodronate is not protective in lethal viral encephalitis despite substantially reducing inflammatory monocyte infiltration in the CNS
by: Alanna G. Spiteri, et al.
Published: (2023-07-01)